The effect of estrogens and antiestrogens in rat models of hot flush

Drug Development Research

Volumn 66, Issue 2, 2005, Pages 182-188

  Merchenthaler, Istvan ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Estrogen; Raloxifene; SERM; Tail skin temperature; Tamoxifen; Tibolone

Indexed keywords

ANTIESTROGEN; ESTROGEN; ETHINYLESTRADIOL; MORPHINE SULFATE; NALOXONE; OPIATE ANTAGONIST; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TIBOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLIMACTERIUM; CONTROLLED STUDY; FEMALE; HOT FLUSH; NONHUMAN; OVARIECTOMY; RAT; SKIN TEMPERATURE; TREATMENT OUTCOME;

EID: 33644848656     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20057     Document Type: Article

References (34)

1. Baker VL, Jaffe RB. 1996. Clinical uses of antiestrogens. Obstet Gynecol Surv 51:45-59.
2. Basaria S, Dobs A. 2003. Andropause: to treat or not to treat? J Endocrin Invest 26:693-697.
3. Berendsen HH, Weekers AH, Kloosterboer HJ. 2001. Effect of tibolone and raloxifene on the tail temperature of oestrogen-deficient rats. Eur J Pharmacol 419:47-54.
4. Birge SJ. 1996. Is there a role for estrogen replacement therapy in the prevention and treatment of dementia?. J Am Geriatr Soc 44:865-870 (see accompanying comment).
5. Craft RM, Stratmann JA, Bartok RE, Walpole TI, King SJ. 1999. Sex differences in development of morphine tolerance and dependence in the rat. Psychopharmacology 143:1-7.
6. Erlik Y, Meldrum DR, Judd HL. 1982. Estrogen levels in postmenopausal women with hot flashes. Obstet Gynecol 59:403-407.
7. Fornander T, Rutqvist LE. 1989. Adjuvant tamoxifen and second cancers. Lancet 1:616.
8. Funkhouser J, Merchenthaler I. 2001. Premarin and two of its components (delta 8,9-dihydroestrone sulfate and estrone sulfate) block hot flushes in a rat model. Annual Meeting, The Endocrine Society: Denver, Colorado, p 2-162.
9. Jelinek J, Kappen A, Schonbaum E, Lomax P. 1984. A primate model of human postmenopausal hot flushes. J Clin Endocrinol Metab 59:1224-1228.
10. Katovich MJ, O'Meara J. 1987. Effect of chronic estrogen on the skin temperature response to naloxone in morphine-dependent rats. Can J Physiol Pharmacol 65:563-567.
11. Katovich MJ, Simpkins JW, Berglund LA, O'Meara J. 1986. Regional skin temperature changes in a rat model for the menopausal hot flush. Maturitas 8:67-76.
12. Katovich MJ, Simpkins JW, Barney CC. 1987. Alpha-adrenergic mediation of the tail skin temperature response to naloxone in morphine-dependent rats. Brain Res 426:55-61.
13. Kloosterboer HJ. 2001. Tibolone: a steroid with a tissue-specific mode of action. J Steroid Biochem Mol Biol 76:231-238.
14. Kronenberg F. 1990. Hot flashes: epidemiology and physiology. Ann NY Acad Sci 592:52-86 (see discussion on p 123-133).
15. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA. 1997. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138:863-870.
16. Leventhal L, O'Connor L, Sipe K, Funkhouser J, Johnston G, Deecher D, Merchenthaler I. 2002. Validation of rat models for hot flush. Annual Meeting, Society for Neuroscience: Miami, Florida.
17. Lomax P, Schonbaum E. 1993. Postmenopausal hot flushes and their management. Pharmacol Therapeut 57:347-358.
18. Loprinzi CL, Goldberg RM, O'Fallon JR, Quella SK, Miser AW, Mynderse LA, Brown LD, Tschetter LK, Wilwerding MB, Dose AM, Oesterling JE. 1994. Transdermal clonidine for ameliorating post-orchiectomy hot flashes. J Urol 151:634-646.
19. Love RR, Wiebe DA, Newcomb PA, Cameron L, Leventhal H, Jordan VC, Feyzi J, DeMets DL. 1991. Effects of tamoxifen on cardiovascular risk factors in postmenopausal women. Ann Intern Med 115:860-864.
20. McKinlay SM, Jefferys M. 1974. The menopausal syndrome. Br J Prevent Social Med 28:108-115.
21. Merchenthaler I, Funkhouser JM, Carver JM, Lundeen SG, Ghosh K, Winneker RC. 1998. The effect of estrogens and antiestrogens in a rat model for hot flush. Maturitas. 30:307-316.
22. Nagamani M, Kelver ME, Smith ER. 1987. Treatment of menopausal hot flashes with transdermal administration of clonidine. Am J Obstet Gynecol 156:561-565.
23. Nomikos G, Spyraki C, Kazandjian A, Sfikakis A. 1987. Estrogen treatment to ovariectomized rats modifies morphine-induced behavior. Pharmacol Biochem Behav 27:611-617.
24. Reddy DS, Kulkarni SK. 1997. Chronic neurosteroid treatment prevents the development of morphine tolerance and attenuates abstinence behavior in mice. Eur J Pharmacol 337:19-25.
25. Scott JA, Da Camara CC, Early JE. 1999. Raloxifene: a selective estrogen receptor modulator. Am Fam Physician 60:1131-1139 (see accompanying comment).
26. Simpkins JW, Katovich MJ, Song IC. 1983. Similarities between morphine withdrawal in the rat and the menopausal hot flush. Life Sci 32:1957-1966.
27. Speroff L. 1996. Postmenopausal hormone therapy and breast cancer. Obstet Gynecol 87(Suppl):44S-54S.
28. Thompson CA, Shanafelt TD, Loprinzi CL. 2003. Andropause: symptom management for prostate cancer patients treated with hormonal ablation. Oncologist 8:474-487.
29. Tulandi T, Lal S, Kinch RA. 1983. Effect of intravenous clonidine on menopausal flushing and luteinizing hormone secretion. Br J Obstet Gynaecol 90:854-857.
30. Waldinger MD, Berendsen HH, Schweitzer DH. 2000. Treatment of hot flushes with mirtazapine: four case reports. Maturitas 36:165-168.
31. Whiteman MK, Staropoli CA, Benedict JC, Borgeest C, Flaws JA. 2003. Risk factors for hot flashes in midlife women. J Womens Health 12:459-472.
32. Wren BG, Brown LB. 1986. A double-blind trial with clonidine and a placebo to treat hot flushes. Med J Austral 144:369-370.
33. Wyllie MG. 2005. Andropause on the move? BJU Int 95:671-672.
34. Yen SS. 1977. The biology of menopause. J Reprod Med 18:287-296.